Overview
- A pilot study of 22 esophageal adenocarcinoma patients showed that a 16-week structured exercise program during chemotherapy increased tumor infiltration by CD8+ T cells and natural killer cells.
- Patients who improved aerobic fitness exhibited stronger immune responses in their tumors and developed mature tertiary lymphoid structures linked to better outcomes.
- The OPTIMUS trial is now recruiting 50 patients and will compare standard versus higher-intensity exercise regimens administered before surgery.
- Preliminary data from seven OPTIMUS participants include cases of undetectable tumors at surgery, a result normally seen in only about 6% of patients.
- Exercise participants entered surgery in better physical condition and experienced smoother recovery, suggesting prehabilitation may mitigate surgical stress.